LOS GATOS, CA – October 23, 2013 – Annai Systems Inc., a genomic data management solution provider, today announced the broader availability of GTFuse for license and download by authorized users of The Cancer Genome Atlas and TARGET data stored in CGHub. GTFuse is an innovative software application that speeds data analysis and enables researchers to more efficiently derive meaningful information from DNA sequencing files by providing access to segments within large data files, offering a shortcut to analysis that was only previously available in Annai Systems’ BioCompute Farm.
“GTFuse has enabled us to rapidly process TCGA sequencing data without the need to transfer large BAM files,” said Dr. Hannah Carter, Department of Medicine, UC San Diego School of Medicine. “I can mount multiple BAMs and process them in parallel in the secure environment provided by the Annai Biocompute Farm, saving us time and money.”
GTFuse allows a researcher to gain access to relevant data without the need to download large sequencing files (often hundreds of gigabytes in size) to their local environment. With this expanded access, researchers now have the option to take advantage of the unique capabilities of GTFuse outside of Annai’s BioCompute Farm. The primary benefit of these capabilities is that researchers can gain quicker access to data, analysis and meaning.
“GTFuse represents the evolution of the Annai-GNOS™ platform, which is the underlying infrastructure that CGHub is built upon,” said Michael Penley, CEO of Annai Systems. “By enabling researchers to access genomic data in a manner that considerably reduces their IT and analysis burden, they can now focus on finding clinically relevant variants, rather than file movement and management.”
GTFuse is available to researchers on an annual license fee basis and is user-installable, allowing customers to begin using this tool immediately.
About Annai Systems
Annai Systems is a leading genomic data analysis company committed to developing cost-reducing innovations the accelerate scientific discovery, maximize statistical power, and optimize data control. From data compression and storage to secondary and tertiary analysis, Annai Systems offers a true end-to-end solution designed to handle the complex needs of next-generation sequencing data in the clinical, pharmaceutical and research environments. The company’s flagship product, STARPlatform, enables researchers to innovate, collaborate, and make new discoveries – all in less time and at lower costs than traditional solutions. For more about Annai Systems, visit www.annaisystems.com.